Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter T Silberstein

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
Systemic Therapy in Metastatic MelanomaGaurav Goyal, Peter T Silberstein
Cureus|December 24, 2024
Patient and Tumor Factors on Overall Survival in Spindle Cell MelanomaXinxin Wu, Peter T Silberstein
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
Colorectal Carcinoma and Emerging Targeted TherapiesNabin Khanal, Smrity Upadhyay, Peter T Silberstein
Immunotherapy|May 19, 2020
So slow, so fast, a case of nivolumab-induced hypothyroidism with subsequent rhabdomyolysisKamelah Abushalha, Sawsan Abulaimoun, Peter T Silberstein
Clinical Lymphoma, Myeloma & Leukemia|December 26, 2015
Trends in Use of Radiation Therapy for Hodgkin Lymphoma From 2000 to 2012 on the Basis of the National Cancer Data BaseGaurav Goyal, Peter T Silberstein, James O Armitage
Clinical Genitourinary Cancer|September 5, 2017
Survival Outcomes of Radical Prostatectomy Versus Radiotherapy in Intermediate-Risk Prostate Cancer: A NCDB StudySydney Marsh, Ryan W Walters, Peter T Silberstein
Journal of Clinical and Experimental Hematopathology : JCEH|June 25, 2015
Double-Hit LymphomaGaurav Goyal, Gabriel C Caponetti, Peter T Silberstein
Journal of Palliative Medicine|July 6, 2010
Palliative chemotherapy: an outdated term for life-prolonging systemic therapies for incurable malignanciesWilson I Gonsalves, Jamil Abuzetun, Peter T Silberstein
Patient Related Outcome Measures|February 3, 2018
Impact of siltuximab on patient-related outcomes in multicentric Castleman's diseaseJenna Sitenga, Gregory Aird, Aabra Ahmed, et al.
Current Oncology (Toronto, Ont.)|April 25, 2025
Equivalent Disease-Specific Survival Between Rural and Urban Osteosarcoma Patients: A Retrospective Analysis of the SEER DatabaseKate S Woods, Mitchell A Taylor, Peter T Silberstein
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
Systemic Therapy in Metastatic MelanomaGaurav Goyal, Peter T Silberstein
Cureus|December 24, 2024
Patient and Tumor Factors on Overall Survival in Spindle Cell MelanomaXinxin Wu, Peter T Silberstein
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
Colorectal Carcinoma and Emerging Targeted TherapiesNabin Khanal, Smrity Upadhyay, Peter T Silberstein
Immunotherapy|May 19, 2020
So slow, so fast, a case of nivolumab-induced hypothyroidism with subsequent rhabdomyolysisKamelah Abushalha, Sawsan Abulaimoun, Peter T Silberstein
Clinical Lymphoma, Myeloma & Leukemia|December 26, 2015
Trends in Use of Radiation Therapy for Hodgkin Lymphoma From 2000 to 2012 on the Basis of the National Cancer Data BaseGaurav Goyal, Peter T Silberstein, James O Armitage
Clinical Genitourinary Cancer|September 5, 2017
Survival Outcomes of Radical Prostatectomy Versus Radiotherapy in Intermediate-Risk Prostate Cancer: A NCDB StudySydney Marsh, Ryan W Walters, Peter T Silberstein
Journal of Clinical and Experimental Hematopathology : JCEH|June 25, 2015
Double-Hit LymphomaGaurav Goyal, Gabriel C Caponetti, Peter T Silberstein
Journal of Palliative Medicine|July 6, 2010
Palliative chemotherapy: an outdated term for life-prolonging systemic therapies for incurable malignanciesWilson I Gonsalves, Jamil Abuzetun, Peter T Silberstein
Patient Related Outcome Measures|February 3, 2018
Impact of siltuximab on patient-related outcomes in multicentric Castleman's diseaseJenna Sitenga, Gregory Aird, Aabra Ahmed, et al.
Current Oncology (Toronto, Ont.)|April 25, 2025
Equivalent Disease-Specific Survival Between Rural and Urban Osteosarcoma Patients: A Retrospective Analysis of the SEER DatabaseKate S Woods, Mitchell A Taylor, Peter T Silberstein
Pageof 8